Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
national blog main
national top stories
8
×
life sciences
san francisco blog main
boston blog main
boston top stories
san francisco top stories
deals
boston
new york blog main
startups
fda
medical devices
new york top stories
dna
investing
san diego blog main
san diego top stories
san francisco
vc
acetylon pharmaceuticals
agios therapeutics
alex gorsky
ambys medicines
arboretum ventures
ashley mcevoy
atrial fibrillation
auris health
aurora health care
azacitidine
baird capital
base editing
beta-thalassemia
biobucks
biofourmis
biovotion
boston scientific
branden moriarty
broad institute
What
startup
8
×
therapeutics
deal
million
adding
based
biotech
medicine
medicines
new
step
acquire
acquiring
aiming
aims
ambys
analytics
ann
approach
arbor
atrial
auris
beam
bets
big
billion
biofourmis
boost
boston
builds
business
buy
called
cancer
cas
cash
closed
company
company’s
continues
Language
unset
Current search:
biotech
×
startup
×
" national top stories "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M